Skip to main content

Advertisement

SpringerLink
Log in

The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Supportive care CPGs are intended to improve the quality of supportive care received by cancer patients. They hold potential benefits for health-care professionals, health-care organizations and patients. In order to provide an effective influence of CPGs on supportive care development in CEE countries their validity and successful implementation in clinical practice must be ensured. This would involve several important steps: (1) achievement of a consensus across Europe about what constitutes supportive care in cancer; (2) identification of supportive care priorities in CEE countries to be covered by the guidelines; and (3) searching existing CPGs relevant to previously identified priorities. Valid international CPGs could then be translated and adapted to local resources and circumstances in CEE countries and used to prepare national supportive care CPGs which could assist in the development of national supportive care standards. Skills, expertise and additional investment are required for local adaptation, dissemination and implementation of international supportive care CPGs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. AGREE Collaboration (2003) Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 12:18–23

    Article  PubMed  Google Scholar 

  2. Ahmedzai SH, Walsh D (2000) Palliative medicine and modern cancer care. Semin Oncol 27:1–6

    CAS  Google Scholar 

  3. American Pain Society (1999) Principles of analgesic use in the treatment of acute pain and cancer pain, 4th edn. American Pain Society, Glenview, IL

  4. American Society of Clinical Oncology (1992) Cancer pain assessment and treatment curriculum guidelines. J Clin Oncol 10:1976–1982

    PubMed  Google Scholar 

  5. American Society of Health-System Pharmacists (1999) Therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 56:729–764

    PubMed  Google Scholar 

  6. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (1998) Prevention of chemotherapy and radiotherapy-induced emesis: results of the Perugia consensus conference. Ann Oncol 9:811–819

    PubMed  Google Scholar 

  7. Berenson JR, Hillner BE, Kyle RA, et al (2002) American Society of Clinical Oncology Clinical Practice Guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 20:3719–3736

    Article  PubMed  Google Scholar 

  8. Bosnjak S (2002) Are Central and Eastern European Countries involved in clinical trials of supportive care. Support Care Cancer 10:303–308

    Article  PubMed  Google Scholar 

  9. Browman GP, Levine MN, Mohide EA, et al (1995) The practice guidelines development cycle: a conceptual tool for practice guideline development and implementation. J Clin Oncol 13:502–512

    CAS  PubMed  Google Scholar 

  10. Cherny N, Ripamonti C, Pereira J, et al (2001) Strategies to manage the adverse effects of oral morphine: an evidence based report. J Clin Oncol 19:2542–2554

    CAS  PubMed  Google Scholar 

  11. Cherny NI, Catane R, Kosmidis P and the members of the ESMO Taskforce on Supportive and Palliative Care (2003) ESMO Policy on Supportive and Palliative Care. Ann Oncol 14:1335–1337

    Article  PubMed  Google Scholar 

  12. Dranitsaris G, Leung P, Warr D (2001) Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. Support Care Cancer 9:611–618

    Article  CAS  PubMed  Google Scholar 

  13. Entwistle VA, Watt IS, Davis H, et al (1998) Developing information materials to present the findings of technology assessments to consumers: the experience of the NHS Centre for Reviews and Dissemination. Int J Tech Assess Health Care 14:47–70

    CAS  Google Scholar 

  14. European Society for Medical Oncology (2001) ESMO minimum clinical recommendations—the beginning of a process. Ann Oncol 12:1037–1038

    Article  PubMed  Google Scholar 

  15. Feder G, Eccles M, Grol R, et al (1999) Clinical guidelines: using clinical guidelines. BMJ 318:728–730

    PubMed  Google Scholar 

  16. Field MJ, Lohr KN (1990) Clinical practice guidelines—directions for a new program. Institute of Medicine, National Academy Press, Washington

  17. Gralla RJ, Osoba D, Kris MG, et al, for the American Society of Clinical Oncology (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971–2994

    CAS  PubMed  Google Scholar 

  18. Grimshaw JM, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317–1322

    CAS  PubMed  Google Scholar 

  19. Hanks GW, de Conno F, Cherny N, et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593

    Google Scholar 

  20. Hansen HH, Bjerre-Jepsen M (2002) A rewarding enterprise. In: European Society for Medical Oncology. ESMO Biennial Report 2001–2002. Interprint, Lugano, pp 38–44

  21. Hansen HH, Bjerre-Jepsen M, Hossfeld D (1999) The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task Force. Ann Oncol 10 [Suppl 6]:S9–S13

  22. Haward RA (1998) Preparing guidelines and documented clinical policies. Ann Oncol 9:1073–1078

    Article  PubMed  Google Scholar 

  23. Herrstedt J (1993) Classical areas in supportive care. Proceedings of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology, 15th International Symposium, Berlin, Germany

  24. Herrstedt J (2001) ESMO recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV). Ann Oncol 12:1059–1060

    PubMed  Google Scholar 

  25. Italian Group for Antiemetic Research (1998) Transferability to clinical practice of the results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Ann Oncol 9:759–765

    PubMed  Google Scholar 

  26. Jacox A, Carr DB, Payne R, et al (1994) Management of cancer pain (AHCPR publication no. 94-0592). US Department of Health and Human Services, Rockville, MD

  27. Klastersky J (1993) Unmasking MASCC. Support Care Cancer 1:2

    PubMed  Google Scholar 

  28. Koeller JM, Aapro MS, Gralla RJ, et al (2002) Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer 10:519–522

    Article  PubMed  Google Scholar 

  29. Luebbe AS, Ahmedzai S, van den Eynden B, et al, on behalf of the EORTC Task Force for Pain and Symptom Control (2003) Towards a European standard for supportive care in cancer patients. Support Care Cancer 11:425

    Google Scholar 

  30. Mertens WC, Higby DJ, Brown D, et al (2003) Improving the care of patients with regard to chemotherapy induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines. J Clin Oncol 21:1373–1378

    Article  PubMed  Google Scholar 

  31. Miaskowski C (2000) Pain care guidelines. In: Lande SD, Kulich RJ (eds) Managed care and pain. American Pain Society, pp 121–140

  32. Mock A, Atkinson A, Barsevick, et al (2003) NCCN (version.1.2003) Cancer Related Fatigue Clinical Practice Guidelines in Oncology. J Natl Comprehensive Cancer Network 1:308–331

    Google Scholar 

  33. National Comprehensive Cancer Network and the American Cancer Society (2001) NCCN/ACS cancer pain treatment guidelines for patients. http://www.nccn.org/patient_gls/_english/_pain/index.htm

  34. National Comprehensive Cancer Network and the American Cancer Society (2001) NCCN/ACS nausea and vomiting treatment guidelines for patients with cancer. http://www.nccn.org/patient_gls/_english/_nausea_and_vomiting/index.htm

  35. National Comprehensive Cancer Network (2003) NCCN Antiemesis Guideline (version 1.2003). The Complete Library of NCCN Clinical Practice Guidelines in Oncology (CD-ROM). NCCN, Rockledge, PA

  36. National Comprehensive Cancer Network (2003) NCCN Cancer pain Guideline (version 1.2002), The Complete Library of NCCN Clinical Practice Guidelines in Oncology (CD-ROM). NCCN, Rockledge, PA

  37. Oncology Nursing Society (2001) Chemotherapy and biotherapy: guidelines and recommendations for practice. Oncology Nursing Society, Pittsburgh, PA

    Google Scholar 

  38. Roberts R (1999) Information for evidence-based care. Radcliffe Medical Press, Oxford

  39. Scottish Intercollegiate Guidelines Network (2000) Control of pain in patients with cancer. A national clinical guideline (publication no. 44). SIGN, Edinburgh

  40. Shekelle PG, Woolf SH, Eccles M, et al (1999) Clinical guidelines: developing guidelines. BMJ 318:593–596

    CAS  PubMed  Google Scholar 

  41. Sikora K, Advani S, Koroltchouk V, et al (1999) Essential drugs for cancer therapy: a World Health Organization consultation. Ann Oncol 10:385–390

    Article  PubMed  Google Scholar 

  42. Warr D, Bramwell V, Anderson D, et al, for the Systemic Treatment Disease Site Group (2001) Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. Curr Oncol 8:69–82

    Google Scholar 

  43. Woolf SH, Grol R, Hutchinson A, et al (1998) Clinical guidelines: the potential benefits, limitations, and harms of clinical guidelines. BMJ 318:527–530

    Google Scholar 

  44. World Health Organization (1986) Cancer pain relief. WHO, Geneva

  45. World Health Organization (1996) Cancer pain relief: with a guide to opioid availability, 2nd ed. WHO, Geneva

    Google Scholar 

Download references

Acknowledgments

My sincere thanks go to Prof. S.H. Ahmedzai, Director of the Sheffield Palliative Care Studies Group, and Prof. D. Clark, Associate Director, for critical review of the manuscript and for their valuable comments during its preparation.

Author information

Authors and Affiliations

  1. Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, FR Yugoslavia

    Snezana Bosnjak

Authors
  1. Snezana Bosnjak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Snezana Bosnjak.

Additional information

This work was presented as an invited lecture at the 15th International Symposium Supportive Care in Cancer, Berlin, Germany, 18–21 June 2003.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bosnjak, S. The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries. Support Care Cancer 11, 775–779 (2003). https://doi.org/10.1007/s00520-003-0538-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-003-0538-5

Keywords

Search

Navigation